Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Recruiting
Phase 1
Interventional Study
Cone-Rod Degeneration
Rod-Cone Degeneration
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 5 – 120
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 165 (estimated)
- Sponsor
- National Eye Institute (NEI) · NIH
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background:
The retina is a thin layer of tissue at the back of the eye. Retinal disease usually reduces a person s mobility because it affects how he or she moves through familiar and unfamiliar environments. Researchers want to see if a virtual reality (VR) tool can provide an easier and more accurate way to assess mobility.
Objective:
To learn if researchers can track changes in mobility in …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
* INCLUSION CRITERIA:
To be eligible, the following inclusion criteria must be met.
1. For the NEI site: Participant must be five years of age or older.
2. For the USyd site: Participant must be thirteen (13) years of age or older.
3. Participant (or legal guardian) must understand and be willing …
Contacts